Astoria Portfolio Advisors’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$504K Buy
5,497
+906
+20% +$79.3K 0.09% 184
2026
Q1
$386K Sell
4,591
-30
-0.6% -$2.67K 0.08% 183
2025
Q4
$449K Sell
4,621
-190
-4% -$14.9K 0.1% 152
2025
Q3
$375K Sell
4,811
-5,518
-53% -$471K 0.1% 169
2025
Q2
$914K Sell
10,329
-43
-0.4% -$3.93K 0.26% 80
2025
Q1
$974K Buy
10,372
+7,463
+257% +$668K 0.33% 75
2024
Q4
$255K Buy
2,909
+825
+40% +$78.7K 0.09% 178
2024
Q3
$209K Buy
+2,084
New +$212K 0.07% 198
2022
Q1
– Sell
-2,459
Closed -$210K – 136
2021
Q4
$210K Buy
+2,459
New +$192K 0.17% 134

Other funds holding CL

Astoria Portfolio Advisors's CL Position: Q2 2026 in Review

Astoria Portfolio Advisors increased its Colgate-Palmolive (CL) stake by 20% in Q2 2026, buying an estimated $79.3K and bringing the position to 5,497 shares worth $504K. The position accounts for 0.09% of the portfolio, ranked #184.

Astoria Portfolio Advisors first reported a position in CL in Q4 2021 and has held it in 9 quarters since. The position peaked at $974K in Q1 2025. 2,028 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Astoria Portfolio Advisors held 5,497 shares of Colgate-Palmolive worth $504K as of Q2 2026.
  • Astoria Portfolio Advisors bought 906 Colgate-Palmolive shares in Q2 2026, an estimated $79.3K.
  • Colgate-Palmolive made up 0.09% of Astoria Portfolio Advisors's portfolio in Q2 2026, its #184 holding.
  • Astoria Portfolio Advisors first reported a position in Colgate-Palmolive in Q4 2021 and has held it in 9 quarters since.
  • Astoria Portfolio Advisors's Colgate-Palmolive position peaked at $974K in Q1 2025.
  • 2,028 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Astoria Portfolio Advisors's 13F filing for Q2 2026, filed 28 Jul 2026.